z-logo
Premium
Cationized ferritin as a magnetic resonance imaging probe to detect microstructural changes in a rat model of non‐alcoholic steatohepatitis
Author(s) -
Beeman Scott C.,
Mandarino Lawrence J.,
Georges Joseph F.,
Bennett Kevin M.
Publication year - 2013
Publication title -
magnetic resonance in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.696
H-Index - 225
eISSN - 1522-2594
pISSN - 0740-3194
DOI - 10.1002/mrm.24619
Subject(s) - steatohepatitis , ferritin , perisinusoidal space , magnetic resonance imaging , pathology , chronic liver disease , fatty liver , parenchyma , chemistry , alcoholic liver disease , liver disease , steatosis , nuclear magnetic resonance , medicine , endocrinology , biochemistry , hepatocyte , cirrhosis , disease , radiology , in vitro , physics
Purpose The goal of this work was to detect disease‐related microstructural changes to the liver using magnetic resonance imaging. Chronic liver disease can cause microstructural changes in the liver that reduce plasma access to the perisinusoidal space—the site of exchange between the blood plasma and the hepatic parenchyma. The reduced plasma access to the perisinusoidal space inhibits hepatic function and contributes to the ∼30,000 chronic liver disease‐related deaths per year. Methods The extracellular matrix‐specific cationized ferritin magnetic resonance imaging probe was injected intravenously into healthy rats and a rat model of the chronic liver disease non‐alcoholic steatohepatitis. Rats were subsequently imaged withT 2 * ‐weighted magnetic resonance imaging. Results This work demonstrates that the binding of cationized ferritin to the perisinusoidal extracellular matrix is reduced by 55% in a rat model of non‐alcoholic steatohepatitis compared to healthy controls. This reduced binding is detectable in vivo with magnetic resonance imaging. Immunofluorescence and electron microscopy indicated that the reduced binding is due to inhibited macromolecular access to the perisinusoidal space caused by non‐alcoholic steatohepatitis‐related microstructural changes. Conclusions The reduced accumulation of intravenously injected cationized ferritin may report on changes in macromolecular access to the liver parenchyma in chronic liver disease. Magn Reson Med 70:1728–1738, 2013. © 2013 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here